← Back to all trials
Completed
NCT03691922
Erector Spinae Block Versus Shoulder Periarticular Anesthetic Infiltration for Arthroscopic Shoulder Surgery
Conditions: Arthroscopic Shoulder Surgery
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 62
Sponsor: McMaster University
Location: St. Joseph's Healthcare Hamilton Hamilton Ontario
Summary
Arthroscopic shoulder surgery is a common and minimally invasive procedure utilized for different shoulder pathologies, but it is often associated with moderate to severe postoperative pain that may interfere with patients' well-being and course of recovery. By using an effective analgesic technique with few side effects, a patient may experience less pain after surgery, have a shortened hospital stay, and endure less nausea, vomiting, or excessive drowsiness that are associated with the use of opioids to manage postoperative pain. Periarticular infiltration (PAI) with local anesthetic (LA) has been used for shoulder surgery pain management, but the more effective interscalene nerve block (ISNB) is the current gold standard analgesic modality despite risk of significant side effects including diaphragm paralysis and rebound pain. In this study, the investigators want to look at the effectiveness and safety profile of a novel technique for pain management after shoulder surgery that has the potential to provide successful pain relief with minimal risk of side effects. Half of the patients will be randomly selected to receive the novel nerve block called the Erector Spinae Plane (ESP) block while the other half will receive a more standard PAI of local anesthetic to numb the shoulder. Patients' pain intensity and opioid consumption in the post-anesthesia care unit (PACU) as well as during the first 24 hours after surgery will be evaluated. Any complications from the interventions will also be noted. The investigators predict that the ESP block will provide superior analgesia compared to PAI for these shoulder arthroscopy patients.
Eligibility Criteria
Inclusion Criteria:
* elective arthroscopic shoulder joint surgeries admitted for day surgical procedure
* an ability to provide informed consent
Exclusion Criteria:
* not willing
* contraindications to spinal injections as per the American Society of Regional Anesthesia and Pain (ASRA) guidelines
* known allergy to LA
* allergy to all opioid medications
* diagnostic shoulder arthroscopic procedures
* inability to understand or comprehend in English language
* history of daily opioid medication use for the last one month
* patients with planned overnight hospital stay
Source: ClinicalTrials.gov (NCT03691922). StuddyBuddy aggregates publicly available trial information.